Form EFFECT Estrella Immunopharma,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 23, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HARO Happy Hour Returns to Scottsdale, and Brands Can Enter the HARO Gift Bag for Free
- Spago Shanghai Welcomes Wolfgang Puck and Byron Lazaroff‑Puck for The Generational Tasting Tour
- ABio materials Co., Ltd. Launches “Celexo AAPE,” a Multi-Care Hair Booster for the Scalp and Hair, Powered by Exosome and PDRN Technologies
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share